News Headlines
- MilliporeSigma Introduces Comprehensive AAV Express Platform For Streamlined Gene Therapy Production 10/17/2025
-
Peptinovo Chooses Ardena To Manufacture Novel Cancer Nanotherapy
10/16/2025
Peptinovo Biopharma, a biotechnology company pioneering targeted cancer therapies through its proprietary PALM nanotechnology, today announced a strategic manufacturing partnership with Ardena, a specialist pharmaceutical contract development and manufacturing organization (CDMO) and bioanalytical contract research organization (CRO) enabling precision medicines and other complex therapies.
-
Syngene International Invests In Dedicated Peptide Laboratory And Advanced Automation
10/15/2025
Syngene International, a global contract research, development, and manufacturing organization (CRDMO), announced site upgrades to accelerate drug discovery and development, helping clients bring novel therapies to market faster.
-
Viatris Completes Acquisition Of Aculys Pharma Including Exclusive Rights To Pitolisant In Japan And To Spydia® In Japan And Certain Other Markets In The Asia-Pacific Region
10/15/2025
Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced it has acquired Aculys Pharma, Inc., a clinical stage biopharmaceutical company focused on commercializing innovative treatments for neurological conditions.
-
Avantor® And BlueWhale Bio Partner To Accelerate CAR-T Manufacturing With Breakthrough Cell Activation And Expansion Technology
10/15/2025
Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies industries, today announced a strategic partnership with BlueWhale Bio, a commercial-stage company dedicated to transforming immune cell therapy manufacturing and addressing the unmet need in CAR-T production by streamlining manufacturing, reducing variability, and shortening time-to-patient.
-
Codis Launches As Global CDMO For Commercial Spray Drying And Amorphous Solid Dispersions
10/14/2025
Codis officially launches as a new global CDMO specializing in commercial-scale spray drying, amorphous solid dispersions (ASD), and particle engineering technologies.
-
Ensera Launches As New Brand Identity For SteriPack
10/14/2025
New trading name reflects expanded expertise across design, manufacturing, assembly and packing for global pharma and medical device companies.
-
Jubilant HollisterStier LLC Launches New High-Speed Isolator Based Line, At Its Spokane Manufacturing Facility In The US
10/14/2025
Jubilant Pharmova Limited announced today that Jubilant HollisterStier LLC (JHS)—a wholly owned subsidiary and a leading North American pharmaceutical contract manufacturer, specialising in sterile injectables and serving top global innovator pharma companies—successfully launched its New Sterile Fill & Finish line, third at its Spokane Manufacturing Facility in Washington, US. The launch was marked by the successful production of the inaugural batch, initiating revenue generation from the new Line. This milestone denotes a significant advancement in Jubilant HollisterStier's multi-phase expansion strategy and brings an additional 50% capacity at its Spokane manufacturing facility.
-
GC Biopharma Secures CMO Rights For Shingles Vaccine From Curevo Vaccine
10/13/2025
GC Biopharma (006280.KS), a South Korean biopharmaceutical company, announced today that it has signed an agreement with Curevo Vaccine to secure contract manufacturing (CMO) rights for amezosvatein (development name: CRV-101), a recombinant shingles vaccine currently under clinical development.
-
LTS Expands Its CDMO Capabilities With The Acquisition Of Renaissance Lakewood
10/13/2025
LTS LOHMANN Therapie-Systeme AG ("LTS"), a leading pharmaceutical technology company today announces the acquisition of Renaissance Lakewood, LLC ("Renaissance"), a US-based contract development and manufacturing organization (CDMO) specializing in nasal sprays and sterile dosage forms.